Circulating lipids and cardiovascular risk in newly diagnosed non- insulin-dependent diabetic subjects in India

Diabetic Medicine

Volumn 14, Issue 9, 1997, Pages 757-761

  Shelgikar, K M ^a   Naik, S S ^a   Khopkar, M ^a   Bhat, D S ^a   Raut, K N ^a   Joglekar, C V ^a   Gerard, M E ^a   Yajnik, C S ^a  

^a KEM HOSPITAL   (India)

Author keywords

Electrocardiogram; Indians; Lipids; Non insulin dependent diabetes

Indexed keywords

3 HYDROXYBUTYRIC ACID; CHOLESTEROL; FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INDIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

3-HYDROXYBUTYRIC ACID; ADULT; ALBUMINURIA; ANGINA PECTORIS; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GLYCEROL; HUMANS; HYDROXYBUTYRATES; INDIA; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 0030863943     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199709)14:9<757::AID-DIA472>3.0.CO;2-8     Document Type: Article

References (26)

1. Ramachandran A. Epidemiology of NIDDM in Indians. Int J Diab Dev Countries 1995; 15: 42-44.
2. Editorial. Coronary heart disease in Indians overseas. Lancet 1986; i: 1307.
3. McKeigue PM, Miller GJ, Marmot MC. Coronary heart disease in South Asians overseas - a review. J Clin Epidemiol 1989; 42: 597-609.
4. McKeigue PM, Marmot MG, Syndercombe Court YD, Cottier DE, Rahman S, Riemersma RA. Diabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in East London. Br Heart J 1988; 60: 390-396.
5. Hughes LO, Cruickshank JK, Wright J, Raftery EB. Disturbances of insulin in British Asian and white men surviving myocardial infarction. Br Med J 1989; 299: 537-540.
6. Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, et al. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet 1995; 345: 405-409.
7. Shelgikar KM, Hockaday TDR, Yajnik CS. Central rather than generalized obesity is related to hyperglycemia in Indian subjects. Diabetic Med 1991; 8: 712-717.
8. Yajnik CS, Naik SS, Bhat DS, Joshi VM, Shelgikar KM, Alberti KGMM, et al. The relationship between obesity, plasma immunoreactive insulin concentration and blood pressure in newly diagnosed Indian Type 2 diabetic patients. Diabetic Med 1993; 10: 146-151.
9. WHO Study Group. Diabetes Mellitus 1985. Technical Report Series 727. Geneva: WHO.
10. Parker KM, England JD, Da Costa J, Hess R, Goldstein DE. Improved colorimetric assay for glycosylated haemoglobin. Clin Chem 1981; 27: 669-672.
11. Morgan CR, Lazarow A. Immunoassay of insulin: two antibody system. Plasma insulin levels in normal, subdiabetic and diabetic rats. Diabetes 1963; 12: 115-126.
12. Alberti KGMM, Record CO, Williamson DH, Wright R, Metabolic changes in active chronic hepatitis. Clin Sci 1972; 42: 591-605.
13. Yajnik CS, Naik SS, Raut KN, Khade AD, Bhat DS, Nagarkar VD, et al. Urinary albumin excretion rate (AER) in newly diagnosed Type 2 diabetic patients is associated with central obesity and hyperglycemia. Diab Res Clin Pract 1992; 17: 55-60.
14. Harris MI. Hypercholesterolemia in individuals with diabetes and glucose intolerance in the U.S. population. Diabetes Care 1991; 14: 366-374.
15. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study XII: Differences between Asian, Afro-Caribbean and white Caucasian Type 2 diabetic patients at diagnosis of diabetes. Diabetic Med 1994; 11: 670-677.
16. Detection and management of lipid disorders in diabetes. In: Clinical Practice Recommendations 1996, American Diabetes Association. Diabetes Care 1996; 19 (suppl 1): S96-S102.
17. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989; 32: 300-304.
18. Burchfiel CM, Hamman RF, Marshall JA, Baxter J, Kahn LB, Amirani JJ. Cardiovascular risk factors and impaired glucose tolerance: the San Luis Valley diabetes study. Am J Epidemiol 1990; 131: 57-70.
19. Austin MA. Plasma triglycerides and coronary heart disease. Arterioscler Thromb 1991; 11: 2-14.
20. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
21. Hulley SB, Rosenman RH, Barool RD, Brand RJ. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. New Engl J Med 1980; 302: 1383-1389.
22. Modan M, Halkin H, Almog S, Lusky A, Eskol A, Shefi M, et al. Hyperinsulinaemia: a link between hypertension, obesity, and glucose intolerance. J Clin Invest 1985; 75: 809-817.
23. Reaven GM, Lerner RL, Stern MP, Farquhar JW. Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 1967; 46: 1756-1767.
24. Bjorntorp P. Obesity, insulin resistance and diabetes. In: Alberti KGMM, Krall LP, eds. The Diabetes Annual/6. Amsterdam: Elsevier, 1991; 347-370.
25. Sarvotham SG, Berry JN. Prevalence of coronary heart disease in urban population in northern India. Circulation 1968; 37: 939-953.
26. Gupta R, Sharma S. Prevalence of asymptomatic electrocardiographic abnormalities in a rural population. J Asso Phys Ind 1996; 44: 775-777.